Medical/Pharmaceuticals News & Press Release Distribution

The Firm of John Dickinson Schneider, Inc. Commemorates 100th Anniversary

LIBERTYVILLE, Ill., May 10, 2021 /PRNewswire/ -- Hollister Incorporated and KMT Medical celebrate Founder's Day today, recognizing the 100th anniversary of their parent company, The Firm of John Dickinson Schneider Inc. (JDS Inc.). A commemorative event celebrating the founder of JDS Inc.,John Di...

2021-05-10 22:00 3118

The Firm of John Dickinson Schneider, Inc. Commemorates 100th Anniversary

Novavax Announces Positive Preclinical Data for Combination Influenza and COVID-19 Vaccine Candidate

- Manuscript highlights development of robust responses to both influenza and COVID-19 and protection against the SARS-CoV-2 virus - Data shared via preprint server for biology, bioRxiv, ahead of publication GAITHERSBURG, Md., May 10, 2021 /PRNewswire/ -- Novavax, Inc. (Nasdaq: NVAX), a biotechn...

2021-05-10 21:55 4649

Eurosets Lauded by Frost & Sullivan for its Integrated ECLS System, ECMOLife

Eurosets' ECMOLife device provides safe therapies for ARDS patients by minimizing the risks inherent in mechanical ventilation and for patients with severely compromised heart and lungs functions. LONDON, May 10, 2021 /PRNewswire/ -- Based on its recent analysis of the global extracorporeal memb...

2021-05-10 21:00 1648

Eurosets Lauded by Frost & Sullivan for its Integrated ECLS System, ECMOLife

DOORwaY-90 study for SIR-Spheres® therapy as first-line treatment for hepatocellular carcinoma enrolls first patient

First prospective multicenter U.S.-based trial for indication expansion of SIR-Spheres® Y-90 resin microspheres taking place in 15 sites across the U.S. WOBURN, Mass., May 10, 2021 /PRNewswire/ -- Sirtex Medical ("Sirtex"), a leading manufacturer of targeted liver cancer therapies, announced that...

2021-05-10 20:30 1366

PharmAbcine Announces Encouraging Non-clinical Data of PMC-403 at the Association for Research in Vision and Ophthalmology (ARVO) 2021 Annual Meeting

DAEJEON, South Korea, May 10, 2021 /PRNewswire/ -- PharmAbcine Inc. (KOSDAQ: 208340ks), a clinical-stage biotech company focusing on the development of antibody therapeutics, announced today that the company presented an e-poster featuring non-clinical data of PMC-403 at the Association for Resea...

2021-05-10 20:00 1825

Thrombectomy Stroke Treatment Reversing Paralysis and Preventing Death Gets Its Global Day

The first annual "World Stroke Thrombectomy Day" is declared on May 15, 2021 by The Society of Vascular and Interventional Neurology Mission Thrombectomy 2020+ Initiative. MINNEAPOLIS, May 10, 2021 /PRNewswire/ -- The Society of Vascular and Interventional Neurology (SVIN) Mission Thrombectomy 2...

2021-05-10 20:00 1330

INOVIO Announces Positive Data from Phase 2 Segment of Clinical Trial Evaluating INO-4800, its COVID-19 DNA Vaccine

PLYMOUTH MEETING, Pa., May 10, 2021 /PRNewswire/ -- INOVIO (NASDAQ:INO), a biotechnology company focused on bringing to market precisely designed DNA medicines to treat and protect people from infectious diseases, cancer, and HPV-associated diseases, today announced positive safety, tolerability ...

2021-05-10 20:00 4124

Viva Biotech and BioMap Reached a Strategic Collaboration Agreement, To Jointly Accelerate the Early Drug Discovery through AI Technology

SHANGHAI, May 10, 2021 /PRNewswire/ -- Hosted by BioMap and Adock, the first generation of China Biocomputing Conference was successfully launched in Suzhou. The conference is aiming to unite with biotech and IT industry partners to create a multi-party integrated industrial ecosystem, and realiz...

2021-05-10 18:21 2972

Bionomics BNC210 Expansion into Social Anxiety Disorder

* Rapid oral absorption of BNC210 novel tablet formulation ideally suited for acute treatment of anxiety in patients with Social Anxiety Disorder * BNC210 Phase 2b PTSD trial on target for start in mid-2021 with U.S. CRO Premier Research selected and clinical site identification underway * P...

2021-05-10 18:00 3684

Invitation to the presentation of Elekta's fiscal year 2020/21

STOCKHOLM, May 10, 2021 /PRNewswire/ -- Elekta (EKTA-B.ST) invites analysts and investors to a presentation of the fiscal year 2020/21 at10:00 a.m. CEST on May 28. The year-end report will be published at 7:30 a.m. CET on the same day.The company's development will be presented by Elekta's Presid...

2021-05-10 17:43 2552

CAPA-IVM a promising advance in assisted reproduction for women with PCOS

SINGAPORE, May 10, 2021 /PRNewswire/ -- The first births and on-going well-being of babies born from an advanced assisted reproduction process called CAPA in-vitro oocyte maturation, or IVM, has highlighted the potential of the procedure for millions of women with complex fertility issues includi...

2021-05-10 13:00 2182

Hong Kong government endorses INDICAID(R) in visitation resumption arrangements

HONG KONG, May 10, 2021 /PRNewswire/ -- COVID-19 rapid antigen test (RAT) INDICAID®, developed by Hong Kong biotechnology start-up PHASE Scientific International Limited (PHASE), has been named by the government as one of the designated rapid tests when care homes resume visitation today. The end...

2021-05-10 11:30 1924

New focus on male factors critical for success in human fertility treatment

SINGAPORE, May 10, 2021 /PRNewswire/ -- The adverse impact of male factors in assisted reproductive treatments was brought into a clear and disturbing focus at the 10th Congress of the Asia Pacific Initiative on Reproduction (ASPIRE). The ASPIRE Congress, originally to be held in the Philippine...

2021-05-10 10:06 1614

Hong Kong government endorses INDICAID(R) in visitation resumption arrangements

HONG KONG, May 10, 2021 /PRNewswire/ -- COVID-19 rapid antigen test (RAT) INDICAID®, developed by Hong Kong biotechnology start-up PHASE Scientific International Limited (PHASE), has been named by the government as one of the designated rapid tests when care homes resume visitation today. The end...

2021-05-10 10:00 2090

Hong Kong Government Endorses INDICAID® in Visitation Resumption Arrangements

HONG KONG, May 10, 2021 /PRNewswire/ -- COVID-19 rapid antigen test (RAT) INDICAID®, developed by Hong Kong biotechnology start-up PHASE Scientific International Limited (PHASE), has been named by the government as one of the designated rapid tests when care homes resume visitation today. The end...

2021-05-10 09:36 3945

Alebund Pharmaceuticals Raises $60 million in Series B Financing Round to Accelerate Its Development of Innovative Drugs and Total Solutions for the Treatment of Renal Diseases

SHANGHAI, May 9, 2021 /PRNewswire/ -- Alebund Pharmaceuticals ("Alebund" or the "Company"), a biopharmaceutical company dedicated to developing innovative therapies for the treatment of renal diseases and related chronic conditions, today announced that it has raised$60 million in its Series B fi...

2021-05-10 08:13 1802

Improving access and affordability of fertility treatment in low to middle income countries

SINGAPORE, May 8, 2021 /PRNewswire/ -- Mounting concerns about access to infertility treatment in low to middle income countries and measures to address the problem have come into sharp focus at the 10th Congress of the Asia Pacific Initiative on Reproduction (ASPIRE). Countries including Indo...

2021-05-08 15:09 2984

Daewoong showed improved performance both sales and earnings in Q1

* OP. income exceeded 20 billion won due to successful export of Fexuprazan and sales recovery * Nabota(botulinum toxin) revenue soared after settlement, historical high performance in March * Turnaround in earnings just started and will continue to 2H SEOUL, South Korea, May 7, 2021 /PRNew...

2021-05-07 21:00 5189

Vakrangee Enters The Online Space With The Launch Of Digital Services

- Through this, company has evolved into the unique O2O (Online to Offline) platform, whereby there is Assistance available through the 10,000+ Physical Kendra store network along with Digital Online Services - Initiated this Unique Hybrid proposition with launch of first Digital service of Tele...

2021-05-07 14:08 4396

WuXi Biologics Completed Three Acquisitions to Enhance its Global Network

SHANGHAI, May 7, 2021 /PRNewswire/ -- WuXi Biologics ("WuXi Bio") (2269.HK), a global company with leading open-access biologics technology platforms, announced that it has completed the acquisitions of a Bayer manufacturing facility in Wuppertal,Germany, the Pfizer China ("Pfizer") manufacturing...

2021-05-07 08:30 5673